Status
Conditions
About
This study aims to determine, for the first time, if miRNA-371a-3p can be used as an accurate biomarker to identify which small (≤ 2cm) testicular masses are malignant and aid in clinical decision-making to offer surgery or surveillance. We propose a retrospective exploration of banked serum, plasma and semen specimens of men with small testis masses and a prospective biomarker-based intervention trial to validate miR-371a-3p performance.
Full description
Study Intervention:
Blinded measurement of miRNA expression in blood and/or seminal plasma after the decision of treatment choice has been made. Participants will undergo usual clinical care and follow a program of surveillance or surgical removal based on a clinician and patient shared decision.
Primary Objective: To determine if surveillance can be offered as a biomarker-based strategy to patients with solitary small testicular masses (STMs) ≤ 2cm.
Secondary Objectives: 1)To assess the performance characteristics of serum, plasma, and seminal plasma miRNA in a prospectively collected cohort of patients presenting with solitary masses small testicular masses ≤ 2cm.
2)To determine the association between miRNA and the presence of testicular cancer in radical or partial orchiectomy surgical specimens.
3)To evaluate surveillance as a treatment strategy in patients with STMs, negative serum tumour markers and negative miRNA secretion, assessing treatment-free survival (TFS) and metastasis free survival (MFS).
4)Refining analytic methods in miRNA assessment by inter-lab comparison, determining best practices and optimal cut-offs to develop a CLIA-approved assay.
5)To establish an optimal threshold for considering an incidentally found testis mass as a small testicular mass.
Endpoints of the study:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Small testicular mass/masses ≤ 2cm
Exclusion criteria
• Patients with testicular tumours > 2 cm
Loading...
Central trial contact
Robert Hamilton, MD; Talha Chaudhry, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal